Structural allele-specific patterns adopted by epitopes in the MHC-I cleft and reconstruction of MHC:Peptide complexes to cross-reactivity assessment

PLoS ONE

Volumn 5, Issue 4, 2010, Pages

  Antunes, Dinler A ^a   Vieira, Gustavo F ^a   Rigo, Maurício M ^a   Cibulski, Samuel P ^a   Sinigaglia, Marialva ^a   Chies, José A B ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA A2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NONSTRUCTURAL PROTEIN 3; HLA ANTIGEN CLASS 1;

ALLELE; AMINO ACID SEQUENCE; ARTICLE; AUTOIMMUNITY; COMPLEX FORMATION; COMPUTER MODEL; CONTROLLED STUDY; CROSS REACTION; CRYSTAL STRUCTURE; IMMUNE RESPONSE; IMMUNOGENICITY; MOLECULAR DOCKING; PROTEIN CONFORMATION; PROTEIN DATA BANK; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SIMULATION; WILD TYPE; ANTIGEN PRESENTATION; BIOLOGY; CHEMISTRY; COMPUTER SIMULATION; CONFORMATION; HUMAN; IMMUNOLOGY; MAJOR HISTOCOMPATIBILITY COMPLEX; METABOLISM; METHODOLOGY; PROTEIN BINDING; PROTEIN DATABASE;

ALLELES; ANTIGEN PRESENTATION; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; CROSS REACTIONS; DATABASES, PROTEIN; EPITOPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR CONFORMATION; PROTEIN BINDING;

EID: 77956408196     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010353     Document Type: Article

References (48)

1. Yewdell JW, Bennink JR (1999) Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu Rev Immunol 17: 51-88.
2. Welsh RM, Selin LK, Szomolanyi-Tsuda E (2004) Immunological memory to viral infections. Annu Rev Immunol 22: 711-743.
3. Wilson DB, Wilson DH, Schroder K, Pinilla C, Blondelle S, et al. (2004) Specificity and degeneracy of T cells. Mol Immunol 40: 1047-1055.
4. Welsh RM, Fujinami RS (2007) Pathogenic epitopes, heterologous immunity and vaccine design. Nat Rev Microbiol 5: 555-563.
5. Welsh RM, Selin LK (2002) No one is naive: the significance of heterologous Tcell immunity. Nat Rev Immunol 2: 417-426.
6. Ang CW, Jacobs BC, Laman JD (2004) The Guillain-Barre syndrome: a true case of molecular mimicry. Trends Immunol 25: 61-66.
7. Sandalova T, Michaelsson J, Harris RA, Odeberg J, Schneider G, et al. (2005) A structural basis for CD8+ T cell-dependent recognition of non-homologous peptide ligands: implications for molecular mimicry in autoreactivity. J Biol Chem 280: 27069-27075.
8. Apostolopoulos V, Lofthouse SA, Popovski V, Chelvanayagam G, Sandrin MS, et al. (1998) Peptide mimics of a tumor antigen induce functional cytotoxic T cells. Nat Biotechnol 16: 276-280.
9. Wedemeyer H, Mizukoshi E, Davis AR, Bennink JR, Rehermann B (2001) Cross-reactivity between hepatitis C virus and Influenza A virus determinantspecific cytotoxic T cells. J Virol 75: 11392-11400.
10. Clute SC, Watkin LB, Cornberg M, Naumov YN, Sullivan JL, et al. (2005) Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis. J Clin Invest 115: 3602-3612.
11. Frankild S, de Boer RJ, Lund O, Nielsen M, Kesmir C (2008) Amino acid similarity accounts for T cell cross-reactivity and for holes in the T cell repertoire. PLoS ONE 3: e1831.
12. Cucchiarini M, Kammer AR, Grabscheid B, Diepolder HM, Gerlach TJ, et al. (2000) Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection. Cell Immunol 203: 111-123.
13. Fytili P, Dalekos GN, Schlaphoff V, Suneetha PV, Sarrazin C, et al. (2008) Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073. Vaccine 26: 3818-3826.
14. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Computational Chemistry 19.
15. Cavasotto CN, Orry AJ (2007) Ligand docking and structure-based virtual screening in drug discovery. Curr Top Med Chem 7: 1006-1014.
16. Kmiecik S, Gront D, Kolinski A (2007) Towards the high-resolution protein structure prediction. Fast refinement of reduced models with all-atom force field. BMC Struct Biol 7: 43.
17. Dibrov A, Myal Y, Leygue E (2009) Computational Modelling of Protein Interactions: Energy Minimization for the Refinement and Scoring of Association Decoys. Acta Biotheor.
18. Rigo MM, Antunes DA, Vieira GF, Chies JAB (2009) MHC:Peptide Analysis: Implications on the Immunogenicity of Hantaviruses N protein. Lect Notes Comput Sci 5676: 160-163.
19. Korber B, LaBute M, Yusim K (2006) Immunoinformatics comes of age. PLoS Comput Biol 2: e71.
20. Lu S (2009) Heterologous prime-boost vaccination. Curr Opin Immunol 21: 346-351.
21. Wang S, Kennedy JS, West K, Montefiori DC, Coley S, et al. (2008) Crosssubtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers. Vaccine 26: 1098-1110.
22. Harari A, Bart PA, Stohr W, Tapia G, Garcia M, et al. (2008) An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses. J Exp Med 205: 63-77.
23. Reali E, Guerrini R, Marastoni M, Tomatis R, Masucci MG, et al. (1999) A single specific amino acid residue in peptide antigens is sufficient to activate memory CTL: potential role of cross-reactive peptides in memory T cell maintenance. J Immunol 162: 106-113.
24. Velloso LM, Michaelsson J, Ljunggren HG, Schneider G, Achour A (2004) Determination of structural principles underlying three different modes of lymphocytic choriomeningitis virus escape from CTL recognition. J Immunol 172: 5504-5511.
25. Tian F, Lv F, Zhou P, Yang Q, Jalbout AF (2008) Toward prediction of binding affinities between the MHC protein and its peptide ligands using quantitative structure-affinity relationship approach. Protein Pept Lett 15: 1033-1043.
26. Meijers R, Lai CC, Yang Y, Liu JH, Zhong W, et al. (2005) Crystal structures of murine MHC Class I H-2 D(b) and K(b) molecules in complex with CTL epitopes from influenza A virus: implications for TCR repertoire selection and immunodominance. J Mol Biol 345: 1099-1110.
27. Borbulevych OY, Insaidoo FK, Baxter TK, Powell DJ, Jr., Johnson LA, et al. (2007) Structures of MART-126/27-35 Peptide/HLA-A2 complexes reveal a remarkable disconnect between antigen structural homology and T cell recognition. J Mol Biol 372: 1123-1136.
28. Buslepp J, Zhao R, Donnini D, Loftus D, Saad M, et al. (2001) T cell activity correlates with oligomeric peptide-major histocompatibility complex binding on T cell surface. J Biol Chem 276: 47320-47328.
29. Zhao R, Loftus DJ, Appella E, Collins EJ (1999) Structural evidence of T cell xeno-reactivity in the absence of molecular mimicry. J Exp Med 189: 359-370.
30. Madurga S, Belda I, Llora X, Giralt E (2005) Design of enhanced agonists through the use of a new virtual screening method: application to peptides that bind class I major histocompatibility complex (MHC) molecules. Protein Sci 14: 2069-2079.
31. Trott O, Olson AJ (2009) AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem.
32. Zhang C, Anderson A, DeLisi C (1998) Structural principles that govern the peptide-binding motifs of class I MHC molecules. J Mol Biol 281: 929-947.
33. Zen J, Treutlein HR, Rudy GB (2001) Predicting sequences and structures of MHC-binding peptides: a computational combinatorial approach. J Comput Aided Mol Des 15: 573-586.
34. Wulf M, Hoehn P, Trinder P (2009) Identification of human MHC class I binding peptides using the iTOPIA- epitope discovery system. Methods Mol Biol 524: 361-367.
35. Zhang H, Lund O, Nielsen M (2009) The PickPocket method for predicting binding specificities for receptors based on receptor pocket similarities: application to MHC-peptide binding. Bioinformatics 25: 1293-1299.
36. Sidney J, Peters B, Frahm N, Brander C, Sette A (2008) HLA class I supertypes: a revised and updated classification. BMC Immunol 9: 1.
37. Sieker F, May A, Zacharias M (2009) Predicting affinity and specificity of antigenic peptide binding to major histocompatibility class I molecules. Curr Protein Pept Sci 10: 286-296.
38. Tong JC, Tan TW, Ranganathan S (2004) Modeling the structure of bound peptide ligands to major histocompatibility complex. Protein Sci 13: 2523-2532.
39. Bordner AJ, Abagyan R (2006) Ab initio prediction of peptide-MHC binding geometry for diverse class I MHC allotypes. Proteins 63: 512-526.
40. Todman SJ, Halling-Brown MD, Davies MN, Flower DR, Kayikci M, et al. (2008) Toward the atomistic simulation of T cell epitopes automated construction of MHC: peptide structures for free energy calculations. J Mol Graph Model 26: 957-961.
41. Waterhouse AM, Procter JB, Martin DM, Clamp M, Barton GJ (2009) Jalview Version 2-a multiple sequence alignment editor and analysis workbench. Bioinformatics 25: 1189-1191.
42. Hall TA (1999) Bioedit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp Ser 41: 95-98.
43. Guex N, Peitsch MC (1997) SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18: 2714-2723.
44. Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, et al. (2005) GROMACS: fast, flexible, and free. J Comput Chem 26: 1701-1718.
45. ME Chen HXC, H Nymeyer NOC.
46. Petrey D, Honig B (2003) GRASP2: visualization, surface properties, and electrostatics of macromolecular structures and sequences. Methods Enzymol 374: 492-509.
47. PyMOL. DeLano Scientific LLC.
48. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, et al. (2004) UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 25: 1605-1612.